keynote SPEAKERS
ProF. Isabelle RAY-COQUARD
Université Claude Bernard Lyon Est, FRANCE
Prof. Ray-Coquard obtained her medical degree in 1997 specializing in oncology. In 2003 she received her PhD from the Université Claude Bernard for her research on the independents factors that determine medical practices in oncology. She also received Master’s degrees in in statistics in 1995 and in medical economy in 1996. From 2008 to 2013, she has served as Chairman of the gynaecologic group for clinical trials of the French National Cancer Institute (INCA) and she is currently the Network Director of the national network dedicated to diagnosis and management of the rare gynecological cancer (www.ovaire-rare.org), a network funded by the INCA commission.
At the Groupe d’investigateurs national evaluation des cancers de l’ovaire (GINECO), she has been active in the translational research advisory committee, the scientific committee, and as a chairman of endometrial cancer subgroup and the rare tumors committee. Since 2002, she is also developing translational research dedicated to ovarian cancer with the INSERM within the CRCL directed by A Puisieux within the CLB campus, and more directly with the research on rare gyn cancer biology (Carcinosarcoma, Granulosa cell tumors).
From 2009 to 2018, she was the chairman of the rare cancer working group from GCIG (gynaecological cancer intergroup) dedicated to clinical trials in the field of all rare gynaecological cancers. She is president of the GINECO group since 2019. Member of the ESGO council since 2021 and Chair of the Gynecological track for ESMO since 2021. She is an active member of a number of professional groups, including the American Society of Clinical Oncology, the Connective Tissue Oncology Society, the French Society of Cancer, the European Association of Cancer Research, the EORTC organisation and the European Society of Medical Oncology (ESMO) and the European Society of Gynaecological Oncology (ESGO).
Gemma Eminowicz
University College London hospital
Gemma Eminowicz is a Consultant Clinical Oncologist and Brachytherapy Lead at University College London hospital (UCLH) and Honorary Clinical Associate Professor at University College London (UCL). Her expertise is complex targeted radiotherapy delivery using image guidance and adaptive techniques as well as systemic therapy for endometrial, cervical and vulvovaginal cancers. She also delivers a broad range of brachytherapy, including gynaecological, oesophageal, bronchus, and paediatric.
She completed her clinical oncology training in 2014 then undertook a MD(Res) at UCL, during which she worked on the INTERLACE trial Radiotherapy Quality Assurance and investigating methods of optimizing radiotherapy delivery for cervical cancer. She is a member of the ESTRO gynae focus group, an active member of GEC-ESTRO, organizer of ESTRO Gyn-SMART webinars and was involved in the GCIG Endometrial cancer consensus conference. Working on many clinical trials including as UK Chief investigator for keynote B21 and a key trial management group member for INTERLACE her passion is to drive forward outcomes using radiotherapy and systemic therapy for women with gynaecological cancers.
PROF. Emma Crosbie
University of Manchester, England
Emma Crosbie an NIHR Advanced Fellow, Professor and Honorary Consultant Gynaecological Oncologist at the University of Manchester. Her research focuses on screening, prevention and early diagnosis of gynaecological cancers. She showed which patients with endometrial cancer should be tested for Lynch syndrome, how they should be tested, that women want to be tested to protect their family members and that testing everyone is cost-effective for the UK National Health System.
This led directly to a change in NICE guidance that all women with endometrial cancer be offered testing for Lynch syndrome. She is Chair of the RCOG Academic Board and member of the RCOG Blair Bell Research Society, roles that enable her to pursue her keen interest in nurturing the next generation of clinical academics. She is Deputy Editor-in-Chief for BJOG and President of Peaches Womb Cancer Trust.
Prof. akila Viswanathan (virtual)
Johns Hopkins University School of Medicine, United States
Akila Viswanathan, M.D., M.P.H., is the director for Johns Hopkins Radiation Oncology and Molecular Radiation Sciences, and a professor of radiation oncology, gynecology/obstetrics and oncology for Johns Hopkins University School of Medicine. Dr. Viswanathan leads the department emphasizing excellence in clinical care, research and education. She has expertise with gynecologic cancers and their treatment, including cervical and uterine cancers and image-guided brachytherapy. She has developed numerous clinical innovations and initiated several system-wide integration efforts at various sites for the Johns Hopkins Department of Radiation Oncology.
Dr. Viswanathan earned her undergraduate degree at Harvard-Radcliffe College, her medical degree at the University of Pittsburgh School of Medicine, followed by her Masters in Public Health and Masters in Epidemiology at the Harvard School of Public Health. She completed a residency in radiation oncology at the Joint Centre for Radiation Therapy at Harvard Medical School, where she served as chief resident. She has had research grant funding through National Cancer Institute programs to support efforts in gynecologic cancers, specifically looking at the identification of gynecologic tumors at the time of brachytherapy under magnetic resonance imaging. The research team has developed several novel clinical innovations.
Dr. Viswanathan served as President and Chair of the Board of the American Brachytherapy Society; Chair of Education Committee for American Society for Radiation Oncology; and, on the Gynecologic Cancer Steering Committee and the uterine cancer task force for the National Cancer Institute. She has published more than 200 articles and chapters, and lectures nationally and internationally. She is the Editor-in-Chief for Seminars in Radiation Oncology. She is on the editorial board of Gynecologic Oncology and Brachytherapy, and is an editor of two textbooks including Gynecologic Radiation Therapy: Novel Approaches to Image-Guidance and Management, and Radiation Therapy Techniques for Gynecologic Cancers.